SPRAVATO (esketamine nasal spray) Patient Assistance Program
Don’t let the high cost of brand specialty depression therapy stand between you and the treatment you need. We help eligible patients access Spravato (esketamine nasal spray) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Spravato (esketamine) is FDA-approved as a nasal spray for treatment-resistant depression (TRD) in adults (in conjunction with an oral antidepressant) and for major depressive disorder with acute suicidal ideation or behavior in adults. It is administered only in REMS-certified healthcare settings.
- Without assistance, the retail cost commonly runs $750–$1,000 per session, with twice-weekly dosing during induction (~$8,000+/month) and weekly or every-other-week maintenance dosing.
- Through AffordMyPrescriptions, qualifying patients can access Spravato for a flat $69.95 per month — our advocacy team manages the entire enrollment, sessions, and renewal process.
- There is no generic version of Spravato available in the U.S. as of 2026. Spravato is dispensed only through certified healthcare facilities under the Spravato REMS program.
What Is Spravato Prescription Assistance Program?
The Spravato Prescription Assistance Program is a manufacturer-sponsored initiative that provides Spravato at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for treatment-resistant depression patients who are uninsured or underinsured, as well as Medicare beneficiaries.
Navigating the program on your own means dealing with eligibility verification, psychiatry coordination, REMS-program enrollment, certified treatment site coordination, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing session-schedule coordination and annual re-certification — so you focus on your mental health care, not paperwork.
Pharmacy Price Comparison
- Without assistance, Spravato sessions cost roughly $750–$1,000 per dose. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Per session (typical) | ~$850.00 | Save ~$780/session |
| Induction (twice-weekly) | ~$6,800/mo | Save ~$6,730/mo |
| Weekly maintenance | ~$3,400/mo | Save ~$3,330/mo |
| Every-2-week maintenance | ~$1,700/mo | Save ~$1,630/mo |
| Annual cost (typical) | ~$30,000+ | Save ~$29,000+/yr |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Spravato Prescription Program?
The Patient Assistance Program is free to apply for and provides Spravato at no medication cost if approved. But the process involves detailed applications, psychiatry coordination, REMS-program enrollment, certified treatment site coordination, session scheduling, and ongoing renewal management. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Spravato:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $750–$1,000 per session per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Spravato assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Spravato Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Spravato:
Spravato (esketamine) is a nasal spray approved for treatment-resistant depression (TRD) in adults — defined as major depressive disorder that has not responded adequately to at least 2 different antidepressants of adequate dose and duration in the current depressive episode — and for major depressive disorder with acute suicidal ideation or behavior. It is administered only in healthcare settings certified under the Spravato REMS program.
How Spravato Works:
Spravato works differently than traditional antidepressants by blocking NMDA glutamate receptors, rather than targeting serotonin or dopamine. This process rapidly increases synaptic plasticity and brain-derived neurotrophic factor, offering relief for treatment-resistant depression sometimes within hours. Because it modulates glutamate signaling, it can be effective for patients who have not responded to multiple standard therapies.
Form and use:
Administered as a nasal spray, Spravato must be used in a certified healthcare setting under direct supervision, followed by at least two hours of monitoring. The treatment schedule typically begins with twice-weekly doses for a month before transitioning to weekly or bi-weekly maintenance sessions. It is always prescribed in conjunction with an oral antidepressant to ensure comprehensive treatment.
Generic availability:
As of 2026, there is no FDA-approved generic version of Spravato available in the United States. While other rapid-acting treatments exist, such as Auvelity or off-label IV ketamine, Spravato remains a unique branded option. The choice of therapy depends on the severity of the depression, the specific indication, and the logistics of accessing a certified administration site.
Warnings:
Spravato carries boxed warnings for sedation, dissociation, and the potential for abuse, requiring it to be managed through a restricted REMS program. Patients are strictly prohibited from driving or operating machinery on the day of administration due to these effects and potential blood pressure increases. Additionally, the medication includes warnings regarding suicidal thoughts and cognitive impairment, necessitating close medical observation.
FAQ (Frequently Asked Questions)
How Much Does Spravato Cost Without Insurance?
Per-session costs commonly run $750–$1,000. During the induction phase (twice weekly for 4 weeks), monthly costs reach $6,800+. Annual costs commonly reach $30,000+ depending on dosing schedule. Through AffordMyPrescriptions, qualifying patients receive Spravato at no medication cost — our $69.95 monthly fee covers full advocacy and program management. (Note: separate facility/administration fees may still apply.)
How Is Spravato Given?
Spravato is administered only in healthcare settings certified under the Spravato REMS program. The patient self-administers the nasal spray under supervision, then is monitored for at least 2 hours. Patients cannot drive home — arrange a ride. Standard dosing for TRD: 56 mg or 84 mg twice weekly for 4 weeks, then weekly for 4 weeks, then every 1 or 2 weeks.
Why Can Spravato Only Be Given In A Healthcare Setting?
Spravato can cause sedation, dissociation, increased blood pressure, and other transient effects that require monitoring. The Spravato REMS program ensures that patients are observed for at least 2 hours after each dose, and that healthcare facilities, prescribers, and pharmacies are all trained on safe-use procedures. This is also why patients cannot self-administer at home or drive on the day of treatment. |
Do I Still Need To Take An Oral Antidepressant?
Yes. Spravato is approved as adjunctive therapy — meaning it is given in addition to an oral antidepressant, not as a replacement for one. Your psychiatry team will continue or adjust your oral antidepressant alongside Spravato treatment.
Can I Get Spravato Through The PAP If I Have Medicare?
Yes. Medicare beneficiaries can typically qualify for Spravato Patient Assistance, especially if you face significant out-of-pocket costs under medical or pharmacy benefits. Coverage of Spravato under Medicare can be complex (Part B vs. Part D depending on setting) — our advocates will help navigate.
What If My Application Is Denied?
If your initial application is denied, we explore alternatives — the manufacturer’s copay assistance program if you have commercial insurance, independent foundations such as the National Alliance on Mental Illness (NAMI), Depression and Bipolar Support Alliance, PAN Foundation, or HealthWell Foundation, or asking your psychiatry team whether a different treatment-resistant depression approach (TMS, off-label IV ketamine, ECT, etc.) would be appropriate. If we cannot find a path, you will not be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Spravato, our team may be able to help you access assistance programs designed to make brand specialty treatment-resistant depression therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.